ARS Pharmaceuticals, Inc Free Cash Flow Generation Index
ARS Pharmaceuticals, Inc free cash flow generation index. ARS Pharmaceuticals, Inc (SPRY) has a Free Cash Flow Generation Index of 0.99x as of December 2024. Free cash flow of $41.70 Million represents 1% of operating cash flow ($42.00 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of ARS Pharmaceuticals, Inc (2020–2024)
Free cash flow generation index of ARS Pharmaceuticals, Inc from 2020 to 2024. Historical FCF Generation Index trend for ARS Pharmaceuticals, Inc across 2 annual periods. See SPRY financial flexibility index to measure the company's free cash flow as a share of total liabilities.
ARS Pharmaceuticals, Inc Free Cash Flow Generation Index by Year (2020–2024)
ARS Pharmaceuticals, Inc free cash flow generation index by year from 2020 to 2024. Year-by-year Free Cash Flow Generation Index for ARS Pharmaceuticals, Inc. For the full cash flow conversion analysis, see ARS Pharmaceuticals, Inc cash conversion from operations.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.96x | $12.98 Million | $13.55 Million | $563.00K | ▲ +6.6% |
| 2020 | 0.90x | $8.15 Million | $9.07 Million | $917.00K | — |